1
|
Davitt CC, Zhang Y, Costales AB. Thinking Twice about the Cervical Mass: A Case Report of Primary Vaginal Leiomyosarcoma and Review of the Literature. Case Rep Obstet Gynecol 2024; 2024:1829000. [PMID: 38591061 PMCID: PMC11001473 DOI: 10.1155/2024/1829000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Revised: 02/13/2024] [Accepted: 02/15/2024] [Indexed: 04/10/2024] Open
Abstract
Primary vaginal leiomyosarcoma (LMS) is an unusual cause of aggressive gynecologic cancer which requires prompt surgical treatment for favorable outcomes. Definitive diagnosis and treatment render unique challenges to clinicians based on vague presentation and limited evidence for management. Here, we describe a case of vaginal LMS in a middle-aged woman with a history of cervical dysplasia found to have a proximal vaginal mass after presenting with vaginal discharge and cramping pain. The patient was diagnosed on pathologic surgical specimen and subsequently underwent definitive surgical treatment. She remains with no evidence of disease 20 months later. In our report, we emphasize the nuances of surgical management including localized source control in those desiring future fertility. Ultimately, we make recommendations for surgical treatment and surveillance based on the available published literature.
Collapse
Affiliation(s)
- Caroline C. Davitt
- Baylor College of Medicine, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Dan L Duncan Comprehensive Cancer Center, 7200 Cambridge St., Houston, TX 77030, USA
| | - Yingao Zhang
- Baylor College of Medicine, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Dan L Duncan Comprehensive Cancer Center, 7200 Cambridge St., Houston, TX 77030, USA
| | - Anthony B. Costales
- Baylor College of Medicine, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Dan L Duncan Comprehensive Cancer Center, 7200 Cambridge St., Houston, TX 77030, USA
| |
Collapse
|
2
|
Yuan H, Wang T. Primary vaginal sarcoma in a single center. Gynecol Oncol Rep 2022; 44:101122. [PMID: 36589507 PMCID: PMC9797610 DOI: 10.1016/j.gore.2022.101122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/13/2022] [Revised: 10/26/2022] [Accepted: 11/23/2022] [Indexed: 12/14/2022] Open
Abstract
Objectives To investigate the clinical characteristics and prognosis of primary vaginal sarcoma. Methods A retrospective analysis of patients with primary vaginal sarcoma treated at our center from 2000 to 2020 was conducted. Results Fifteen patients were identified, among which 9 (60.0 %) patients had leiomyosarcoma, 2 (13.3 %) patients had Ewing's sarcoma, 2 (13.3 %) patients had rhabdomyosarcoma, 1 (6.7 %) patient had undifferentiated sarcoma, and 1 (6.7 %) patient had malignant peripheral schwannoma. Nine patients presented with vaginal mass that was the most common primary symptoms. Eleven patients received their primary surgery, and 7 of them received postoperative adjuvant chemotherapy or radiation therapy. The remaining 4 patients received initial chemotherapy and/or radiotherapy because of advanced stage. The distribution by stage was as follows: stage I in 10 patients, stage II in 1 patient, stage III in 2 patients and stage IV in 2 patients. The median follow-up was 43.7 months (10.1-137.5 months). Thirteen patients (86.7 %) had disease extent during follow-up, and among them, 11 patients (11/13, 84.6 %) developed local relapse or adjacent organ metastases, 1 patient (1/13, 7.7 %) developed liver metastases, and the remaining 1 patient (1/13, 7.7 %) developed lung metastases and local relapse during follow-up. Ten (10/13, 76.9 %) patients relapsed within 2 years after diagnosis. Eight patients (8/11, 72.7 %) with local recurrence or adjacent organ metastases received a secondary surgery treatment, and only 2 of them relapsed again. Two-year overall survival (OS) and 5-year OS were 80.0 % and 66.7 %, respectively. Patients with leiomyosarcoma had a tendency toward a better 5-year OS than those with other sarcomas (74.1 % vs 66.7 %, P = 0.307). Conclusions Primary vaginal sarcomas are aggressive neoplasms with different presenting characteristics. Surgery is the main treatment for primary vaginal sarcoma and for local relapse vaginal sarcoma.
Collapse
Affiliation(s)
- Hua Yuan
- Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China,Corresponding author at: Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
| | - Tonghui Wang
- Clinical Lab, Beijing Bo'ai Hospital, China Rehabilitation Research Center, Beijing, China
| |
Collapse
|
3
|
Yuan H, Wang T. Primary vaginal sarcoma in a single center. Gynecol Oncol Rep 2022; 44:101110. [PMID: 36506036 PMCID: PMC9731389 DOI: 10.1016/j.gore.2022.101110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/13/2022] [Revised: 10/26/2022] [Accepted: 11/23/2022] [Indexed: 11/27/2022] Open
Abstract
Objectives To investigate the clinical characteristics and prognosis of primary vaginal sarcoma. Methods A retrospective analysis of patients with primary vaginal sarcoma treated at our center from 2000 to 2020 was conducted. Results Fifteen patients were identified, among which 9 (60.0 %) patients had leiomyosarcoma, 2 (13.3 %) patients had Ewing's sarcoma, 2 (13.3 %) patients had rhabdomyosarcoma, 1 (6.7 %) patient had undifferentiated sarcoma, and 1 (6.7 %) patient had malignant peripheral schwannoma. Nine patients presented with vaginal mass that was the most common primary symptoms. Eleven patients received their primary surgery, and 7 of them received postoperative adjuvant chemotherapy or radiation therapy. The remaining 4 patients received initial chemotherapy and/or radiotherapy because of advanced stage. The distribution by stage was as follows: stage I in 10 patients, stage II in 1 patient, stage III in 2 patients and stage IV in 2 patients. The median follow-up was 43.7 months (10.1-137.5 months). Thirteen patients (86.7 %) had disease extent during follow-up, and among them, 11 patients (11/13, 84.6 %) developed local relapse or adjacent organ metastases, 1 patient (1/13, 7.7 %) developed liver metastases, and the remaining 1 patient (1/13, 7.7 %) developed lung metastases and local relapse during follow-up. Ten (10/13, 76.9 %) patients relapsed within 2 years after diagnosis. Eight patients (8/11, 72.7 %) with local recurrence or adjacent organ metastases received a secondary surgery treatment, and only 2 of them relapsed again. Two-year overall survival (OS) and 5-year OS were 80.0 % and 66.7 %, respectively. Patients with leiomyosarcoma had a tendency toward a better 5-year OS than those with other sarcomas (74.1 % vs 66.7 %, P = 0.307). Conclusions Primary vaginal sarcomas are aggressive neoplasms with different presenting characteristics. Surgery is the main treatment for primary vaginal sarcoma and for local relapse vaginal sarcoma.
Collapse
Affiliation(s)
- Hua Yuan
- Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China,Corresponding author at: Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
| | - Tonghui Wang
- Clinical Lab, Beijing Bo'ai Hospital, China Rehabilitation Research Center, Beijing, China
| |
Collapse
|
4
|
de Nadai Filho N, Crispi Junior CP, de Freitas Fonseca M. Paracolpium Leiomyoma Misdiagnosed as Endometriosis: Case Report and Surgical Technique of a Laparoscopic Approach. Case Rep Obstet Gynecol 2022; 2022:7931391. [PMID: 35548783 PMCID: PMC9085306 DOI: 10.1155/2022/7931391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2021] [Revised: 03/27/2022] [Accepted: 04/19/2022] [Indexed: 11/18/2022] Open
Abstract
A 36-year-old Caucasian, nulliparous patient sought care at a private gynecology clinic after 6 months of attempting to conceive. During the initial consultation, the patient reported severe dysmenorrhea and deep dyspareunia. During the gynecological examination, a nodule in the left lateral vaginal fornix was palpable. The MRI showed a hypointense nodular lesion in the left paracolpium described as an endometriosis nodule. Laparoscopic resection of the nodule was indicated. The patient showed improvement in symptoms after surgical treatment. This case report describes the technique for laparoscopic approach to paracolpium tumors.
Collapse
Affiliation(s)
- Nilton de Nadai Filho
- Ministro Costa Cavalcanti Hospital, Foz do Iguaçu PR, Brazil
- Crispi Institute of Minimally Invasive Surgery, Rio de Janeiro, RJ, Brazil
- Fernandes Figueira National Institute for Women, Children and Youth Health, Rio de Janeiro, RJ, Brazil
| | | | - Marlon de Freitas Fonseca
- Crispi Institute of Minimally Invasive Surgery, Rio de Janeiro, RJ, Brazil
- Department of Women's Health-Fernandes Figueira National Institute for Women, Children and Youth Health-Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil
| |
Collapse
|
5
|
Vitantri F, Chamim, Shadrina A. Malignant mesenchymal vaginal tumor mimicking pedunculated submucous myoma: A case report. Int J Surg Case Rep 2022; 93:106864. [PMID: 35318185 PMCID: PMC8935506 DOI: 10.1016/j.ijscr.2022.106864] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2022] [Revised: 02/19/2022] [Accepted: 02/22/2022] [Indexed: 11/30/2022] Open
Abstract
Introduction Vaginal mesenchymal cancer is one of the rarest cases, covering only 3% of all cases of vaginal malignancies. While risk factors are not heavily studied, genetic disorders and hereditary diseases have been stated to be responsible for the increasing incidence of vaginal mesenchymal carcinoma. The diagnosis of leiomyosarcoma could be done through anamnesis to find abnormal uterine discharge and pelvic pain and physical examination to find a protruding mass on the vagina, which then should be confirmed through a series of radiologic examinations and histopathological examinations. Due to its rarity, each case should be properly evaluated for its clinical manifestation, diagnostic results, and outcome of the treatment. Case presentation A 46-year-old woman came in with vaginal discharge and a protruding mass from the vagina without bleeding or urinary or defecation difficulties, which was suspected to be pedunculated submucous myoma. Based on pelvic USG and MRI, the mass was suspected to have originated from the vagina. Histopathology examinations from biopsy showed a possible mesenchymal malignant type. The patient then underwent total hysterectomy, bilateral salpingo-oophorectomy, and partial vaginectomy. Histopathological evaluation confirmed the diagnosis of leiomyosarcoma in the patient. Discussion and conclusion The patient was diagnosed with a vaginal malignant mesenchymal tumor stage II intraoperatively and underwent total hysterectomy and bilateral salpingo-oophorectomy. Leiomyosarcoma is not commonly diagnosed preoperatively, hence implying the importance of radiologic examination to do an early diagnosis prior to the histopathological analysis. Due to the rarity of vaginal mesenchymal malignancy, further studies are needed to increase understanding of this case. Vaginal cancer is one of the rarest cases. Mesenchymal type is rare case of vaginal cancer. Vaginal cancer is classified based on FIGO criteria.
Collapse
|
6
|
Perrone AM, Ferioli M, Galuppi A, Coe M, De Terlizzi F, Tesei M, Dondi G, De Palma A, Morganti AG, De Iaco P. Palliative treatment with electrochemotherapy in recurrent or metastatic vaginal cancer. Int J Gynecol Cancer 2020; 30:939-946. [PMID: 32474450 DOI: 10.1136/ijgc-2020-001471] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2020] [Revised: 05/11/2020] [Accepted: 05/13/2020] [Indexed: 12/23/2022] Open
Abstract
OBJECTIVE Vaginal metastases are very rare events with a poor prognosis. To improve the quality of life, local treatments should be considered. The aim of this study was to evaluate the role of electrochemotherapy as palliative treatment in vaginal cancer not amenable to standard treatments due to poor performance status, previous treatments, or advanced disease. METHODS This is a prospective observational study on patients diagnosed with vaginal cancer and treated from January 2017 to December 2018 with palliative electrochemotherapy. We collected data on patients with vaginal cancer treated by electrochemotherapy with the aim of local control. Data regarding electrochemotherapy, hospital stay, adverse events, and patient outcomes were analyzed. Intravenous bleomycin was injected as a bolus in 2-3 min at a dose of 15 000 UI/m2 and electrical pulses started 8 min after chemotherapy. Electrochemotherapy response was defined according to the Response Evaluation Criteria in Solid Tumors. RESULTS Five patients with vaginal recurrence (two squamous, two melanomas, and one leiomyosarcoma) and one with vaginal metastasis from intestinal adenocarcinoma received one treatment and two patients were re-treated. Imaging reported nodal metastasis (inguinal or pelvic) in two patients, distant metastases in two, and both node and distant metastasis in two patients, respectively. Response Evaluation Criteria in Solid Tumors showed a complete response in one patient, partial response in three patients, stable disease in one patient, and progressive disease in one patient, with an overall response rate of 67% and a clinical benefit rate (complete response, partial response, stable disease) of 83%. Two patients were re-treated and had a new response (partial response and stable disease, respectively). At last follow-up, two patients had died of the disease, two were alive with stable disease, one was alive with progressive disease, and one was alive without disease. Median post-electrochemotherapy overall survival was 12.9 months (range 1.6-26.9) and 1-year overall survival was 66.7%. CONCLUSIONS This preliminary experience showed a tumor response or stabilization in 83% of patients requiring palliative management for vaginal cancer. Further studies are needed to evaluate treatment outcome in larger and prospective series.
Collapse
Affiliation(s)
- Anna Myriam Perrone
- Gynecologic Oncology Unit, Azienda Ospedaliero-Universitaria Policlinico di Sant'Orsola, Bologna, Italy .,Centro di Studio e Ricerca delle Neoplasie Ginecologiche (CSR), University of Bologna, Bologna, Italy
| | - Martina Ferioli
- Radiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine, DIMES Univerisity of Bologna, Bologna, Italy
| | - Andrea Galuppi
- Centro di Studio e Ricerca delle Neoplasie Ginecologiche (CSR), University of Bologna, Bologna, Italy.,Radiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine, DIMES Univerisity of Bologna, Bologna, Italy
| | - Manuela Coe
- Department of Experimental, Diagnostic and Specialty Medicine, Unit of Radiology, Azienda Ospedaliero-Universitaria Policlinico di Sant'Orsola, Bologna, Italy
| | | | - Marco Tesei
- Gynecologic Oncology Unit, Azienda Ospedaliero-Universitaria Policlinico di Sant'Orsola, Bologna, Italy.,Centro di Studio e Ricerca delle Neoplasie Ginecologiche (CSR), University of Bologna, Bologna, Italy
| | - Giulia Dondi
- Gynecologic Oncology Unit, Azienda Ospedaliero-Universitaria Policlinico di Sant'Orsola, Bologna, Italy.,Centro di Studio e Ricerca delle Neoplasie Ginecologiche (CSR), University of Bologna, Bologna, Italy
| | - Alessandra De Palma
- Forensic Medicine and Integrated Risk Management Unit, Azienda Ospedaliero-Universitaria Policlinico di Sant'Orsola, Bologna, Italy
| | - Alessio G Morganti
- Centro di Studio e Ricerca delle Neoplasie Ginecologiche (CSR), University of Bologna, Bologna, Italy.,Radiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine, DIMES Univerisity of Bologna, Bologna, Italy
| | - Pierandrea De Iaco
- Gynecologic Oncology Unit, Azienda Ospedaliero-Universitaria Policlinico di Sant'Orsola, Bologna, Italy.,Centro di Studio e Ricerca delle Neoplasie Ginecologiche (CSR), University of Bologna, Bologna, Italy
| |
Collapse
|
7
|
Hagen J, Wilhite A, Tarbunova M, Erickson B. Successful robotic surgery for primary resection of a vaginal leiomyosarcoma: A case report. Gynecol Oncol Rep 2019; 30:100503. [PMID: 31656851 PMCID: PMC6806553 DOI: 10.1016/j.gore.2019.100503] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/12/2019] [Revised: 09/11/2019] [Accepted: 09/15/2019] [Indexed: 12/24/2022] Open
Abstract
Primary vaginal leiomyosarcoma (LMS) is a rare entity with limited data on optimal treatment approach. Most previously reported cases utilize an open or transvaginal surgical approach for primary tumor resection. Minimally invasive surgery is an important tool in complex pelvic surgery and the limits of its utility continue to expand. Here, we report a rare case of an 11.7 cm primary vaginal LMS in a 45-year-old female that was successfully resected with a robotic approach. Our case demonstrates an innovative use of the robot and the feasibility and efficacy of this approach for primary resection of large vaginal tumors.
Collapse
Affiliation(s)
- Jennifer Hagen
- University of Minnesota, Department of Obstetrics, Gynecology, and Women’s Health, 420 Delaware Street, MMC 395, Minneapolis, MN 55455, USA
| | - Annelise Wilhite
- University of Minnesota, Department of Obstetrics, Gynecology, and Women’s Health, 420 Delaware Street, MMC 395, Minneapolis, MN 55455, USA
| | - Maryna Tarbunova
- University of Minnesota, Department of Laboratory Medicine and Pathology, 420 Delaware Street SE, Minneapolis, MN 55455, USA
| | - Britt Erickson
- University of Minnesota, Department of Obstetrics, Gynecology, and Women’s Health, 420 Delaware Street, MMC 395, Minneapolis, MN 55455, USA
| |
Collapse
|
8
|
Khafagy AM, Prescott LS, Malpica A, Westin SN. Unusual indolent behavior of leiomyosarcoma of the vagina: Is observation a viable option? Gynecol Oncol Rep 2017. [PMID: 28649595 PMCID: PMC5472150 DOI: 10.1016/j.gore.2017.06.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
Abstract
Primary leiomyosarcoma of the vagina is a rare disease. We identified a case of unanticipated indolent behavior of vaginal leiomyosarcoma. Observation or hormonal therapy may be viable option for select patients.
Collapse
Affiliation(s)
- Ayatallah M Khafagy
- Department of Obstetrics and Gynecology, Inova Fairfax Hospital, Falls Church, VA 22042, USA
| | - Lauren S Prescott
- Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Anais Malpica
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Shannon N Westin
- Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| |
Collapse
|
9
|
Leiomyoma of the Vulva: A Diagnostic Challenge Case Report. Case Rep Obstet Gynecol 2016; 2016:8780764. [PMID: 27818815 PMCID: PMC5080524 DOI: 10.1155/2016/8780764] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2016] [Accepted: 09/22/2016] [Indexed: 11/18/2022] Open
Abstract
Uterine leiomyomas are common and can affect up to 30% of women older than 35 years. Despite this, leiomyomas of the vulva are rare, masquerading, and usually misdiagnosed as Bartholin cyst preoperatively. These smooth muscle tumors are typically painless, solitary, and well circumscribed and can affect female of any age group. We present a case of a 46-year-old female that presented to the clinic with 2-year history of right labial mass and was diagnosed as Bartholin cyst initially. The patient underwent elective excision under spinal anaesthesia and the mass was removed. The final diagnosis after microscopy result showed benign vulvar leiomyoma.
Collapse
|
10
|
Leiomyosarcoma of the Vagina: An Exceedingly Rare Diagnosis. Case Rep Obstet Gynecol 2015; 2015:363895. [PMID: 26783476 PMCID: PMC4689886 DOI: 10.1155/2015/363895] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2015] [Revised: 11/25/2015] [Accepted: 11/29/2015] [Indexed: 11/24/2022] Open
Abstract
Background. Primary leiomyosarcoma of the vagina is an exceedingly rare diagnosis. Current estimates are that this tumor could at most represent a mere 0.062% of malignant neoplasms in the female genital tract, although in actuality it is likely far less common. Case Presentation. A 70-year-old female gravida 3 para 2 with new onset palpable vaginal mass and pink vaginal discharge is diagnosed with primary leiomyosarcoma of the vagina. Chemotherapy is complicated by acute Lyme disease, and the patient requires a robotic-assisted total hysterectomy with bilateral salpingo-oophorectomy and partial vaginectomy. The patient remains without recurrence 18 months after surgery. Conclusion. Vaginal leiomyosarcoma is exceedingly rare with an aggressive course, high recurrence, and undetermined ideal treatment regimen. Its diagnosis can be delayed and its presentation varied. Information on this rare tumor type is predominantly through rare case reports with collective consensus on management lacking. The gynecologic oncologist must exercise prudence in individualizing treatment regimens for this rare yet aggressive malignancy.
Collapse
|
11
|
Xu Z, Zeng R, Liu J. A large primary retroperitoneal vaginal leiomyosarcoma: a case report. J Med Case Rep 2015; 9:130. [PMID: 26040930 PMCID: PMC4592555 DOI: 10.1186/s13256-015-0599-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2015] [Accepted: 04/27/2015] [Indexed: 11/10/2022] Open
Abstract
INTRODUCTION Primary vaginal leiomyosarcomas are uncommon, especially those growing outside the vagina.Out of all malignant vaginal neoplasms, leiomyosarcomas account for about 2%. Reports in the literature mostly concern the pathology of these tumors; few reports have been published that discuss how to surgically remove them. CASE PRESENTATION A 69-year-old Chinese woman presented with a mass in her buttocks that had been present for more than four months. Computed tomography demonstrated a mass of approximately 12.0×9.5×8.0cm in her retroperitoneal space. We resected the tumor via a posterior incision, and resected part of her sacrum and coccyx. The resected tumor was diagnosed by its pathological features as a leiomyosarcoma. Our patient received adjuvant chemotherapy after surgery. She was free of disease at a one-year follow-up and her general condition is good. CONCLUSIONS We report a rare case of a primary vaginal leiomyosarcoma that was resected through an approach that has not, to the best of our knowledge, been previously reported. This case report adds valuable knowledge to the sparse available literature on the surgical treatment of vaginal leiomyosarcomas.
Collapse
Affiliation(s)
- Zheng Xu
- Department of General Surgery, The 175th Hospital PLA (Affiliated Dongnan Hospital of Xiamen University), No. 269, Zhanghua Middle Road, Zhangzhou City, Fujian Province, 363000, China.
| | - Rongyao Zeng
- Department of General Surgery, The 175th Hospital PLA (Affiliated Dongnan Hospital of Xiamen University), No. 269, Zhanghua Middle Road, Zhangzhou City, Fujian Province, 363000, China.
| | - Jing Liu
- Department of General Surgery, The 175th Hospital PLA (Affiliated Dongnan Hospital of Xiamen University), No. 269, Zhanghua Middle Road, Zhangzhou City, Fujian Province, 363000, China.
| |
Collapse
|